月度归档： 2026 年 5 月

New York-based foodtech investor Big Idea Ventures has announced 5 new additions to its Global Food Innovation Fund II (GFIF II), with the latest cohort spanning fermentation, plant cell biomanufacturing, cold chain stabilization, bioactive delivery, and enzyme-based extraction.

Boston Consulting Group (BCG) and Women’s Wear Daily (WWD) have reported that consumers are combining various beauty methods to optimize skin results. This burgeoning approach to beauty may become vastly lucrative in the coming years.

The US Army Combat Capabilities Development Command Soldier Center (DEVCOM-SC) has issued a Sources Sought Announcement seeking industry and academic partners to advance alternative protein technologies for integration into military field rations, with a response deadline of May 15, 2026.

Paula’s Choice has been named the Official Skincare Sponsor of the FIFA World Cup 2026 and the FIFA Women’s World Cup 2027, as beauty brands increasingly turn to sport to expand cultural relevance and connect skin care with performance, resilience, and wellness.

Estonian biotech company ÄIO has obtained COSMOS certification from Cosmécert for three of its fermentation-derived cosmetic ingredients: RedOil (INCI: Rhodotorula Oil), ZymaLipid Complex (INCI: Linoleic/Oleic/Palmitic Acid), and Encapsulated Oil (INCI: Rhodotorula Ferment).

A 14-member expert panel convened by Healthy Eating Research (HER) has released a technical report recommending that certain ultra-processed foods (UPFs) be treated differently under US policy, arguing that blanket restrictions on the category risk penalizing foods with demonstrated health benefits, including many plant-based products.

Ingredient distributor ACI Group has published a white paper arguing that hybrid meat products, which blend conventional animal protein with plant-based ingredients, represent a more commercially viable emissions reduction strategy than full substitution.

Vegan movement-building incubator Kickstarting For Good (K4G) has reported that its 2025 graduate cohort collectively raised more than $1.5 million within six months of completing the programme, an 85% increase on the funding secured by the previous year’s graduates over the same period.

More than one million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, optic nerves, and spine. MS is characterized by overwhelming fatigue, muscle spasms, and vision problems, which can flare up and then subside over days, months, or even years. Studying the underlying damage to the nervous system is key to identifying new treatment paradigms for MS.